... relapses of COVID-19, requiring several admissions. This study evaluated the clinical characteristics and outcomes after treatment of 5 patients with follicular lymphoma (FL), previously treated with ICT, who developed several episodes of COVID-19. Methods: We analyzed the clinical evolution and response...

...Alexey Glazyrin; Chirag Patel; Lara Kujtan; Sheshadri Madhusudhana Low-grade follicular lymphomas are genetically characterized by the translocation t(14; 18)(q32;q21) with BCL2 gene rearrangements. Marginal zone lymphomas are often associated with translocations or transcriptional deregulations...

... Italiano Studio Linfomi (GISL) Single-agent bortezomib (B) has shown activity in heavily pretreated patients with relapsed/refractory indolent lymphoma. On the basis of these findings, we performed a phase II study of B combined with rituximab (R) in patients with relapsed follicular lymphoma (FL). Forty...

...Hiromi Koiso; Akihiko Yokohama; Takeki Mitsui; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Junko Hirato; Masaru Kojima; Yoshihisa Nojima; Norifumi Tsukamoto Marked splenomegaly as the main presenting sign in follicular lymphoma (FL) is rare. The clinical and morphologic findings of 3 FL...

...Liat Vidal; Anat Gafter-Gvili; Ofer Shpilberg The course of follicular lymphoma has changed considerably with the introduction of immunotherapy. Systematic reviews and meta-analyses are reliable, efficient and well-established methods to summarize the vast amount of data acquired in recent years...

...V. Formica; A.R. Norman; D. Cunningham; A. Wotherspoon; J. Oates; G. Chong Background: The Follicular Lymphoma International Prognostic Index (FLIPI) allows physicians to stratify patients into groups with distinct prognoses, however its ability to predict the treatment efficacy has not been fully...

...H. Deghiedy; M. Fouda; D. Shahin; S. Shamaa; A. El-Bedewy; H. Abd El-Ghaffar Background: Follicular lymphoma (FL) is one of the most common non-Hodgkin’s lymphomas of B cells, being closely associated with a t(14;18) translocation. Detection of t(14;18), which is present in 70–95% of FL, might aid...

... Follicular lymphoma High-dose therapy Mantle cell lymphoma The use of high-dose treatment (HDT) of non-Hodgkin’s lymphoma (NHL) has increased markedly over the last 10 years. However, there has been only one, relatively small, randomized study, the Parma Study, which demonstrated a survival...

...Isabel Krsnik; Julio García-Suárez; Montserrat López-Rubio; Alicia Santana A 55-year-old man suffered a cutaneous relapse of an LMP1-positive follicular lymphoma after treatment with antithymocyte globulin and cyclosporine A (CSA) for a hepatitis-associated aplastic anaemia (AA). Rituximab...